Hawkins, Inc. (HWKN) - 10-K Summary
Business Context and Reporting Period
Company: Hawkins, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: March 29, 2009 (Fiscal 2009)
Business Overview: Hawkins distributes, blends, and manufactures bulk and specialty chemicals. Operations are conducted through two segments: Industrial (agriculture, energy, food, pharmaceuticals) and Water Treatment (municipal and industrial wastewater). The company recently exited its Pharmaceutical segment, reporting results as discontinued operations.
Key Financial Metrics (Fiscal 2009)
| Metric | Fiscal 2009 | Fiscal 2008 |
|---|---|---|
| Sales (Continuing Ops) | $284.4 million | $186.7 million |
| Gross Profit | $62.4 million (22.0% margin) | $38.5 million (20.6% margin) |
| Operating Income | $37.3 million (13.1% margin) | $12.0 million (6.4% margin) |
| Net Income | $23.8 million | $9.1 million |
| Diluted EPS | $2.32 | $0.89 |
| Cash from Operations | $24.4 million | $12.2 million |
| Cash & Equivalents (End of Period) | $29.5 million | $21.5 million |
| Total Assets | $136.3 million | $108.9 million |
| Capital Expenditures | $14.2 million | $5.8 million |
Material Changes vs. Prior Period
- Revenue Surge: Sales increased 52.3% to $284.4 million. This was driven by a 61.8% increase in the Industrial segment and a 33.3% increase in the Water Treatment segment.
- Margin Expansion: Gross profit margin improved to 22.0% from 20.6%. Management attributes this to selling lower-cost inventory during a period of rapidly escalating commodity prices and supply constraints that competitors could not meet.
- LIFO Impact: A significant LIFO charge of $10.0 million reduced gross profit in 2009, compared to $1.3 million in 2008, reflecting rising inventory costs.
- Discontinued Operations: The Pharmaceutical segment was sold in May 2009. Results are now classified as discontinued operations.
- Capital Investment: Capital expenditures more than doubled to $14.2 million, primarily for two new facilities (Centralia, IL and Minneapolis, MN) totaling $7.5 million.
Outlook, Risks, and Management Commentary
Management Outlook: Management expects fiscal 2010 results to return to levels more in line with historic results prior to fiscal 2009. The extraordinary margins achieved in 2009 were due to unique market conditions (supply shortages and rapid price escalation) that have since eased as commodity prices leveled off or declined due to the economic downturn.
Key Risks:
- Commodity Volatility: Prices for raw materials (e.g., caustic soda) are cyclical. The company does not hedge against price fluctuations, exposing margins to volatility.
- Supply Constraints: Dependence on raw material availability; shortages (e.g., potassium chloride in 2008) can disrupt operations.
- Customer Concentration: While no single customer exceeds 10% of sales, the top five customers accounted for $46.0 million (approx. 16%) of sales in 2009.
- Lease Renewals: Three main terminals are on leased land with renewal options extending to 2018 and 2029. Failure to renew could materially impact operations.
- Seasonality: Water Treatment sales are higher from April to September.
Investor Verification Checklist
- Sustainability of Margins: Verify if the 22.0% gross margin is sustainable given the normalization of commodity prices and the removal of the "low-cost inventory" benefit.
- Capital Expenditure ROI: Monitor the operational status and revenue contribution of the new Centralia, IL and Minneapolis, MN facilities.
- Discontinued Operations: Confirm the final accounting treatment and any remaining obligations related to the sale of the Pharmaceutical segment.
- LIFO Reserve: Track the LIFO reserve balance ($14.5 million in 2009) to understand the potential impact of future inventory cost fluctuations on reported earnings.
- Lease Terms: Review the status of lease renewals for the three critical terminal locations.